These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4645276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PURIFICATION OF TOXOHORMONE BY CARBOXYMETHYL-CELLULOSE COLUMN CHROMATOGRAPHY.
    FUJII S, YUASA A, KAWACHI T, OKAMURA Y, WAKASUGI H, YAMAMURA Y.
    Gan; 1964 Feb; 55():67-71. PubMed ID: 14134000
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Fractionation of toxohormone-like principle in urine extracts of patients with carcinoma--comparative studies of the biological activities of carcinoma urine extract, toxohormone and of bacterial lipopolysaccharide].
    Akigawa K.
    Sapporo Igaku Zasshi; 1967 Feb; 32(2):160-73. PubMed ID: 4873062
    [No Abstract] [Full Text] [Related]

  • 7. Immunochemical studies on liver catalase depression by toxohormone.
    Hozumi M, Matsuoka K, Sugimura T.
    Gan; 1967 Dec; 58(6):555-63. PubMed ID: 5589527
    [No Abstract] [Full Text] [Related]

  • 8. Molecular size of in vivo liver catalase-depressing substance from rhodamine sarcoma of rat.
    Matsuo Y, Nishikawa K, Horio T.
    Gan; 1972 Feb; 63(1):95-110. PubMed ID: 5043819
    [No Abstract] [Full Text] [Related]

  • 9. Antitumor and toxohormone-neutralizing activities of human ceruloplasmin.
    Itoh O, Torikai T, Satoh M, Okumura O, Osawa T.
    Gan; 1981 Jun; 72(3):370-6. PubMed ID: 7319196
    [Abstract] [Full Text] [Related]

  • 10. Effects on various types of liver catalase by growth of rhodamine sarcoma and by administration of in vivo catalase-depressing substance prepared from the tumor.
    Nakamura T, Matuo Y, Nishikawa K, Horio T, Okunuki K.
    Gan; 1968 Aug; 59(4):317-25. PubMed ID: 5707406
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of toxohormone on microsomal cytochromes and hydroxylating systems of rat liver.
    Takahashi A, Kato R.
    J Biochem; 1969 Feb; 65(2):325-7. PubMed ID: 5771959
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Toxohormone in bacteria-free tumors.
    Nixon JC, Zinman B.
    Can J Biochem; 1966 Aug; 44(8):1069-87. PubMed ID: 5968598
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and partial characterization of a 67Ga-binding glycoprotein from Morris 5123C rat hepatoma.
    Lawless D, Brown DH, Hübner KF, Colyer SP, Carlton JE, Hayes RL.
    Cancer Res; 1978 Dec; 38(12):4440-4. PubMed ID: 719629
    [Abstract] [Full Text] [Related]

  • 19. In vivo liver catalase-depressing substance from rhodamine sarcoma.
    Matuo Y.
    Gan; 1968 Oct; 59(5):405-13. PubMed ID: 5707975
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of toxohormone, endogenic or isolated from melanoma, on the activity of liver ferrochelatase in the Syrian hamster].
    Grabowska AM, Winter R, Piskorska D.
    Patol Pol; 1980 Oct; 31(1):19-24. PubMed ID: 7190261
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.